Skip to main content

Month: September 2023

WISeKey’s WISe.ART, digital platform powered with cyber security, and CryptoVerse Island announce their support for the Maiti Nepal Foundation with an exclusive sale of art NFT to raise funds for young ladies’ university scholarships in Nep

FOR IMMEDIATE RELEASE WISeKey’s WISe.ART, digital platform powered with cyber security, and CryptoVerse Island announce their support for the Maiti Nepal Foundation with an exclusive sale of art NFT to raise funds for young ladies’ university scholarships in Nepal ZUG, SWITZERLAND – September 6, 2023 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leader in cybersecurity, AI, Blockchain, and IoT operating as a holding company, that WISe.ART will support efforts of the Maiti Nepal Foundation (Maiti Nepal) to sponsor students who are pursuing higher secondary degrees, through funds raised from the sale of selected NFTs donated by artists and made available on the WISe.ART platform. Maiti is a beautiful word from the Nepali language, meaning a woman’s childhood home. Apart from being a beautiful word that...

Continue reading

Idorsia reacquires the world-wide rights to aprocitentan

Ad hoc announcement pursuant to Art. 53 LRAprocitentan, Idorsia’s oral, dual endothelin receptor antagonist is currently under review with health authorities for the treatment of patients with resistant hypertension. Idorsia will pay Janssen a conditional consideration up to a total cap of CHF 306 million Idorsia is initiating activities to determine the best approach to maximize the value of aprocitentan.Allschwil, Switzerland – September 6, 2023Idorsia Ltd (SIX: IDIA) today announced that it has entered into an agreement with Janssen Biotech Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the return of rights for aprocitentan to Idorsia. In return, Idorsia is committed to pay up to 306 million Swiss francs, subject to marketing application approval by the US FDA and Europe’s EMA. Jean-Paul Clozel,...

Continue reading

SalMar capital markets day today in Northern Norway

Frøya/Tromsø, 6. September 2023 When SalMar today welcomes participants to its 2023 Capital Markets Day in Tromsø, sustainable organic growth is on the top of the agenda. Following several successful transactions and the ongoing integration of NTS, NRS and SalmoNor, SalMar has established itself as a powerhouse in the international aquaculture industry. The company will maintain its commitment and ambitions within coastal farming and within offshore farming. SalMar aims to continue its leading role in growing and developing the industry both nationally and internationally.  “Our ambition is further growth in all the regions we operate, but where, how soon and how much we will invest will depend on where we find a sustainable regulatory framework. In Norway, the resource rent tax which has been introduced represents a particular cause for...

Continue reading

VEON confirms unhindered trading of its shares, offers support to its investors

Amsterdam, 6 September 2023 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services (“the Company”), announces that it has issued a CEO Letter to current and potential investors, confirming the unhindered trading of its shares and offering the Company’s support to investors if they experience arbitrary obstacles to trading. In the letter, shared with the investor community on 5 September 2023, VEON Group CEO noted the following: “Dear Valued Investors, I am writing this letter to you to address some stock market observations that have recently come to our attention. We have noted that the trading volumes of our shares are unusually low, and have received reports suggesting that certain brokers are arbitrarily declining orders to purchase VEON shares. Allow...

Continue reading

Novartis appoints Patrick Horber, M.D., President, International as Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, steps down from the Executive Committee of Novartis

After nearly seven years at Novartis and more than four years as a member of the ECN, Ms. Tschudin will pursue her next chapter of leadership outside of NovartisDr. Horber to drive next phase of international growth, shape commercial strategy, and continue Novartis leadership in reimagining medicines for patients around the worldBasel, September 06, 2023 — Novartis today announced that Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave the company and will step down from the Executive Committee of Novartis (ECN), effective September 15, after nearly seven years of commercial leadership at Novartis. Patrick Horber, M.D., currently Senior Vice President and President, Immunology at AbbVie has been appointed as President, International, effective later this year, reporting...

Continue reading

Ontex announces change of Chief Financial Officer

Aalst, Belgium, September 6, 2023 – Ontex Group NV (“Ontex” or, the “Company”), a leading international provider of personal hygiene solutions, announces today that Peter Vanneste, Chief Financial Officer at Ontex, has decided to leave Ontex early October 2023, to pursue a career opportunity outside the Group. His successor will be announced in due time. In the interim the responsibilities of CFO will be assumed by Gustavo Calvo Paz, CEO. Gustavo Calvo Paz, CEO, stated: “We recognize the contribution that Peter Vanneste has made, shaping and executing Ontex’ strategic transformation, including refocusing with successful divestments. He also contributed to guiding the company through the difficult macro-economic conditions with a clear focus on the Group’s financial health and organization. This allowed Ontex to gradually restore profitable...

Continue reading

Kayne Anderson NextGen Energy & Infrastructure Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at August 31, 2023

HOUSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2023. As of August 31, 2023, the Fund’s net assets were $412.1 million and its net asset value per share was $8.73. As of August 31, 2023, the Fund’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 746% and the Fund’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 469%.     Kayne Anderson NextGen Energy & Infrastructure, Inc.Statement of Assets and LiabilitiesAugust 31, 2023(Unaudited)    (in...

Continue reading

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at August 31, 2023

HOUSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of August 31, 2023. As of August 31, 2023, the Company’s net assets were $1.4 billion, and its net asset value per share was $10.22. As of August 31, 2023, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 592% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 434%.Kayne Anderson Energy Infrastructure Fund, Inc.Statement of Assets and LiabilitiesAugust 31, 2023(Unaudited)    (in...

Continue reading

ONWARD Schedules Webcast to Provide Half Year 2023 Business Update

Eindhoven, Sept. 05, 2023 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury, today announced that it will host a webcast to discuss its Half Year 2023 business highlights. The webcast will be held on September 19, 2023, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver and CFO Lara Smith Weber, who will discuss highlights from Half Year 2023 and provide a business update. To join the webcast via Zoom, please register using this link. Participants may also join by phone: +32 2 290 9360 (Belgium)+49 69 3807 9884 (Germany)+31 20 794 0854 (Netherlands)+41 22 591 0156 (Switzerland)+44 203 481 5240 (United Kingdom)+1 346 248 7799 (US) Additional telephone numbers available Webinar...

Continue reading

Timbercreek Financial Comments on Groupe Huot Loans

TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) — Timbercreek Financial Corp. (TSX: TF) (the “Company” or “Timbercreek Financial”) today provided commentary and clarification on its loans to Groupe Huot Inc. (“Groupe Huot”), a Quebec-based real estate developer. As disclosed in the Company’s Q2 2023 financial results, Timbercreek Financial is a secured creditor to Groupe Huot on seven recently constructed, income-producing multi-family assets in Quebec. Several recent media articles have stated that Timbercreek’s investments to Groupe Huot total approximately $253 million. Timbercreek is in the business of originating commercial mortgages and often works with third-party lenders to share loans based on different risk and return criteria. This total amount represents the gross amount of the registered and secured hypothecs (mortgages)....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.